A citation-based method for searching scientific literature

Ajay Varanasi, Natalie Bellini, Deepti Rawal, Mehul Vora, Antoine Makdissi, Sandeep Dhindsa, Ajay Chaudhuri, Paresh Dandona. Eur J Endocrinol 2011
Times Cited: 97







List of shared articles



Times cited

Weight Management in Patients with Type 1 Diabetes and Obesity.
Adham Mottalib, Megan Kasetty, Jessica Y Mar, Taha Elseaidy, Sahar Ashrafzadeh, Osama Hamdy. Curr Diab Rep 2017
29


Addressing Unmet Medical Needs in Type 1 Diabetes: A Review of Drugs Under Development.
Friedrich Mittermayer, Erica Caveney, Claudia De Oliveira, G Alexander Fleming, Loukas Gourgiotis, Mala Puri, Li-Jung Tai, J Rick Turner. Curr Diabetes Rev 2017
7

Dapagliflozin as Additional Treatment to Liraglutide and Insulin in Patients With Type 1 Diabetes.
Nitesh D Kuhadiya, Husam Ghanim, Aditya Mehta, Manisha Garg, Salman Khan, Jeanne Hejna, Barrett Torre, Antoine Makdissi, Ajay Chaudhuri, Manav Batra,[...]. J Clin Endocrinol Metab 2016
39

GLP-1 Receptor Agonists and Type 1 Diabetes - Where Do We Stand?
Djordje S Popovic, Edita Stokic, Stevan L Popovic. Curr Pharm Des 2015
4

How to fight obesity with antidiabetic drugs: targeting gut or kidney?
M Baretić, R Troskot. Minerva Endocrinol 2015
4

Absence of glucagon and insulin action reveals a role for the GLP-1 receptor in endogenous glucose production.
Lucy S Jun, Rohn L Millican, Eric D Hawkins, Debra L Konkol, Aaron D Showalter, Michael E Christe, M Dodson Michael, Kyle W Sloop. Diabetes 2015
36

GLP-1 Agonists in Type 1 Diabetes Mellitus.
Kristin M Janzen, Taylor D Steuber, Sarah A Nisly. Ann Pharmacother 2016
17

The treatment of type 1 diabetes mellitus with agents approved for type 2 diabetes mellitus.
Kashif M Munir, Stephen N Davis. Expert Opin Pharmacother 2015
11

Use of non-insulin therapies for type 1 diabetes.
Satish K Garg, Aaron W Michels, Viral N Shah. Diabetes Technol Ther 2013
8

Liraglutide acutely suppresses glucagon, lipolysis and ketogenesis in type 1 diabetes.
Manisha Garg, Husam Ghanim, Nitesh D Kuhadiya, Kelly Green, Jeanne Hejna, Sanaa Abuaysheh, Barrett Torre, Manav Batra, Antoine Makdissi, Ajay Chaudhuri,[...]. Diabetes Obes Metab 2017
14

The effects of add-on exenatide to insulin on glycemic variability and hypoglycemia in patients with type 1 diabetes mellitus.
L-L Jiang, S-Q Wang, B Ding, J Zhu, T Jing, L Ye, K-O Lee, J-D Wu, J-H Ma. J Endocrinol Invest 2018
5

Efficacy and safety of the glucagon-like peptide-1 receptor agonist liraglutide added to insulin therapy in poorly regulated patients with type 1 diabetes--a protocol for a randomised, double-blind, placebo-controlled study: the Lira-1 study.
Thomas Fremming Dejgaard, Filip Krag Knop, Lise Tarnow, Christian Seerup Frandsen, Tanja Stenbæk Hansen, Thomas Almdal, Jens Juul Holst, Sten Madsbad, Henrik Ullits Andersen. BMJ Open 2015
9